ABA

Alba (ABA)

News di Agenzia

Da:
 Ti mostriamo gli articoli più rilevanti per la tua ricerca:LSE:ABA
DataOraFonteTitoloSimboloCompagnia
09/05/201808:01UK RegulatoryAIM Cancellation - Abaco Capital plcLSE:ABAAbaco Capital
08/05/201815:22Alliance NewsAlliance NewsAbaco Capital Secures Investor Approval For Delisting And Liquidation (ALLISS)LSE:ABAAbaco Capital
08/05/201813:13UK RegulatoryAbaco Capital PLC Result of AGM and Notice of CancellationLSE:ABAAbaco Capital
08/05/201808:44Alliance NewsAlliance News*Abaco Capital Shares Temporarily Suspended From AIM Trading (ALLISS)LSE:ABAAbaco Capital
08/05/201808:30UK RegulatoryAIM Suspension - Abaco Capital plcLSE:ABAAbaco Capital
04/05/201812:09Alliance NewsAlliance NewsAbaco Capital Share Trading To Be Suspended Ahead Of Delisting VoteLSE:ABAAbaco Capital
04/05/201808:00UK RegulatoryAbaco Capital PLC Suspension of trading on AIMLSE:ABAAbaco Capital
06/04/201809:56Alliance NewsAlliance NewsAbaco Capital Proposes AIM Delisting, Fails To Find Takeover Target (ALLISS)LSE:ABAAbaco Capital
06/04/201808:00UK RegulatoryAbaco Capital PLC Proposed Cancellation of AdmissionLSE:ABAAbaco Capital
06/04/201808:00UK RegulatoryAbaco Capital PLC Final ResultsLSE:ABAAbaco Capital
27/02/201808:02UK RegulatoryAbaco Capital PLC Strategy updateLSE:ABAAbaco Capital
21/12/201711:00UK RegulatoryOxford Pharmascience Group PLC Completion of DemergerLSE:ABAAbaco Capital
19/12/201716:50UK RegulatoryOxford Pharmascience Group PLC Confirmation of Capital ReductionsLSE:ABAAbaco Capital
04/12/201715:14UK RegulatoryOxford Pharmascience Group PLC Subdivision of CapitalLSE:ABAAbaco Capital
29/11/201712:09Alliance NewsAlliance NewsOxford Pharmascience Gets US Regulatory Boost For OXPZero ProductLSE:ABAAbaco Capital
29/11/201708:00UK RegulatoryOxford Pharmascience Group PLC FDA Advice on OXPzero Ibuprofen OTC OpportunityLSE:ABAAbaco Capital
27/11/201712:55UK RegulatoryOxford Pharmascience Group PLC Result of General MeetingLSE:ABAAbaco Capital
22/11/201716:03Alliance NewsAlliance NewsOxford Pharmascience Says Richard Griffiths Has Raised Holding To 23% (ALLISS)LSE:ABAAbaco Capital
22/11/201715:48UK RegulatoryOxford Pharmascience Group PLC Holding(s) in CompanyLSE:ABAAbaco Capital
20/11/201717:40UK RegulatoryOxford Pharmascience Group PLC Second Price Monitoring ExtnLSE:ABAAbaco Capital
20/11/201717:35UK RegulatoryOxford Pharmascience Group PLC Price Monitoring ExtensionLSE:ABAAbaco Capital
20/11/201712:48Alliance NewsAlliance NewsOxford Pharmascience Group Gets Regulatory Boost For OXPZero In SwedenLSE:ABAAbaco Capital
20/11/201708:00UK RegulatoryOxford Pharmascience Group PLC MPA Advice on OXPzeroT Ibuprofen OTC OpportunityLSE:ABAAbaco Capital
10/11/201709:53Alliance NewsAlliance NewsOxford Pharmascience Shares Jump As It Announces Demerger (ALLISS)LSE:ABAAbaco Capital
10/11/201708:00UK RegulatoryOxford Pharmascience Group PLC Announcement of demergerLSE:ABAAbaco Capital
02/10/201713:14Alliance NewsAlliance NewsOxford Pharmascience Suspends OXPzero Development As It Mulls AdviceLSE:ABAAbaco Capital
02/10/201711:15UK RegulatoryOxford Pharmascience Group PLC MHRA Advice on OXPzeroT Ibuprofen OTC OpportunityLSE:ABAAbaco Capital
25/09/201712:46Alliance NewsAlliance NewsOxford Pharmascience Loss Widens As Regulatory Hurdles Slow ProgressLSE:ABAAbaco Capital
25/09/201708:00UK RegulatoryOxford Pharmascience Group PLC Interim ResultsLSE:ABAAbaco Capital
19/06/201712:38UK RegulatoryOxford Pharmascience Group PLC Result of AGMLSE:ABAAbaco Capital
 Ti mostriamo gli articoli più rilevanti per la tua ricerca:LSE:ABA
Per accedere al tempo reale push di Borsa è necessario registrarsi.

Accedendo ai servizi offerti da ADVFN, ne si accettano le condizioni generali Termini & Condizioni

ADVFN Network